Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARMK | Common Stock | Options Exercise | $277K | +13.4K | +14.05% | $20.67 | 109K | Mar 5, 2024 | Direct | |
transaction | ARMK | Common Stock | Sale | -$415K | -13.4K | -12.32% | $31.02 | 95.3K | Mar 5, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ARMK | Stock Option (Right to Buy) | Options Exercise | $0 | -13.4K | -100% | $0.00* | 0 | Mar 5, 2024 | Common Stock | 13.4K | $20.67 | Direct | F2 |
Id | Content |
---|---|
F1 | The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.920 to $31.085, inclusive. The reporting person undertakes to provide to Aramark, any security holder of Aramark, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
F2 | These options are fully vested and were set to expire on November 19, 2024. |